Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks

Objectives Magnesium sulfate (MgSO4) is one of the most commonly used agents for the treatment and prophylaxis of eclampsia in patients with severe preeclampsia. However, there is no international consensus regarding the optimal gestational age for MgSO4 treatment. The aim of this study was to asses...

Full description

Saved in:
Bibliographic Details
Main Authors: Baoxiang Xing, Xie Dai, Guoqiang Gao, Ling Liu, Yan Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hypertension in Pregnancy
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10641955.2024.2404459
Tags: Add Tag
No Tags, Be the first to tag this record!